EGFR and glioma: A recent classification of gliomas was based on mutations present in specific genes [8,9,10]; in particular, an integrated genomic analysis identified clinically relevant subtypes of glioblastoma, characterized by abnormalities in PDGFRA, IDH1, EGFR and NF1 [11].